In 2024, there were major advances in inflammatory bowel disease research. Treatment strategies with biologic agents for inflammatory bowel disease matured, and gut microbiota–bacteriophage–host interaction emerged as a new frontier to target.
- Leolin Katsidzira
- Benjamin Misselwitz
